Solesence free cash flow SLSN
Cash from operations less capital spending, by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$849K
- Latest quarter, Q2 FY26
- −$278K
- Fiscal year 2025
- −$10.7M
Solesence's free cash flow was −$849K over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$278K.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2025 | −$10.7M | n/a |
| FY2024 | −$2.6M | n/a |
| FY2023 | −$3.1M | n/a |
| FY2022 | −$4.5M | −1101% |
| FY2021 | $447K | n/a |
| FY2020 | −$2.9M | n/a |
| FY2019 | −$3.5M | n/a |
| FY2018 | −$1.5M | n/a |
| FY2017 | −$1.2M | n/a |
| FY2016 | −$369K | n/a |
| FY2015 | −$520K | n/a |
| FY2014 | −$1.4M | n/a |
| FY2013 | −$801K | n/a |
| FY2012 | −$751.8K | n/a |
| FY2011 | −$3M | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$278K | n/a | −$849K | |
| Q1 FY26 | $989K | n/a | −$2.6M | |
| Q4 FY25 | $1.4M | n/a | −$10.7M | |
| Q3 FY25 | −$2.9M | −205% | −$12.5M | |
| Q2 FY25 | −$2.1M | n/a | −$6.8M | |
| Q1 FY25 | −$7.1M | n/a | −$5.7M | |
| Q4 FY24 | −$404K | n/a | −$2.6M | |
| Q3 FY24 | $2.8M | +9% | −$5M | |
| Q2 FY24 | −$1M | n/a | −$5.3M | |
| Q1 FY24 | −$3.9M | n/a | −$6.2M | |
| Q4 FY23 | −$2.8M | n/a | −$3.1M | |
| Q3 FY23 | $2.6M | +717% | −$486K |
Against its peers
Companies in Consumer Defensive nearest Solesence's size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| SLSNSolesence | −1.5% |
| DITAmcon Distributing | 4.5% |
| AXILAxil Brands | 11.6% |
| RAVERave Restaurant | 11.2% |
| JVACoffee | 31.2% |
| LGCYLegacy Education | 2.0% |
| LWAYLifeway Foods | −9.2% |
| EDUCEducational Development | 2.0% |
| ARKOARKO | 8.6% |
| WEYSWeyco | 9.4% |
| Peer median | 8.6% |
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Solesence
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.